Showing results (121-130 of 210) with videos related to
Sort By:
Pageof 21
Diabetes, Obesity & Metabolism|June 23, 2018
Non-adherence to basal insulin among patients with type 2 diabetes in a US managed care population: Results from a patient surveyJudith J Stephenson, Amit D Raval, David M Kern, et al.Advances in Therapy|December 12, 2018
Bridging the Gap Between Self-Reported and Claims-Derived Adherence Measures for Basal Insulin Among Patients with Type 2 Diabetes MellitusJudith J Stephenson, Jay P Bae, Amit D Raval, et al.Journal of Pain Research|February 6, 2020
Incidence of Opioid Overdose Among Patients Using ER/LA Opioid Analgesics Before and After Implementation of the Class-Wide Opioid Risk Evaluation and Mitigation StrategyDaina B Esposito, M Soledad Cepeda, Crystal N Holick, et al.Archives of Internal Medicine|February 18, 2003
Colon polyp recurrence in a managed care populationMarianne Ulcickas Yood, Susan Oliveria, J Gregory Boyer, et al.Journal of the American Medical Informatics Association : JAMIA|August 6, 2026
REWARD-an open-source framework for identifying the unknown benefits of existing medications to inform drug discovery, development, and repurposingDavid M Kern, Justin Bohn, James P Gilbert, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma AloneMaria Gerhardsson de Verdier, Maria Andersson, David M Kern, et al.Drug Safety|June 4, 2025
Large-scale Empirical Identification of Candidate Comparators for Pharmacoepidemiological StudiesJustin Bohn, James P Gilbert, Christopher Knoll, et al.Advances in Therapy|July 19, 2014
Description of cardiovascular event rates in patients initiating chronic opioid therapy for noncancer pain in observational cohort studies in the US, UK, and GermanyRobert LoCasale, David M Kern, Pierre Chevalier, et al.Pharmacoepidemiology and Drug Safety|December 30, 2017
Methods for time-varying exposure related problems in pharmacoepidemiology: An overviewLaura Pazzagli, Marie Linder, Mingliang Zhang, et al.Journal of Cutaneous Medicine and Surgery|May 16, 2013
Understanding and assessing potential serious adverse events: a practical approach to understanding the benefits and harm of psoriasis treatmentsKim Papp, Lyn Guenther, Neil Shear, et al.Pageof 21